Stryker Corporation shelled out $120 million to purchase Patient Safety Technologies, which makes bar-coded surgical sponges to prevent doctors from leaving sponges in a patient after surgery. Stryker’s patient safety concerns have come under question after two of its hip replacement devices were recalled.
Stryker issued a recall for the Rejuvenate and ABG II hip replacements after studies showed the devices were failing early, causing patients severe side effects. Some of the hip implant side effects included premature loosening of the hip implant, tissue damage and metal poisoning complications.
The company reportedly settled several Stryker hip replacement lawsuits for an undisclosed amount at the end of 2013. Stryker still faces hip implant lawsuits alleging that the company released a defective device, causing injuries and often requiring revision surgery.